ROYSTON IVOR

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$1.84M
Insider Sells Quantity
5
Insider Sells Sum
$252,851.90

Insider Activity of ROYSTON IVOR

The largest purchase of all time was on 2016-03-08 and amounted to 150000 shares of Syndax Pharmaceuticals, Inc. for $1.8M.

The largest sale of all time was on 2021-11-29 and amounted to 15833 shares of Viracta Therapeutics, Inc. for $76,301.

Biography of ROYSTON IVOR

No biography is available at this moment.

2022-08-25SaleViracta Therapeutics, Inc.
VIRX
CEO & President
13,379
0.0334%
$4.01$53,656-59.98%
2022-05-25SaleViracta Therapeutics, Inc.
VIRX
CEO & President
13,162
0.0338%
$1.90$25,022+14.72%
2022-02-28SaleViracta Therapeutics, Inc.
VIRX
CEO & President
14,635
0.0397%
$2.78$40,678+6.23%
2021-11-29SaleViracta Therapeutics, Inc.
VIRX
CEO & President
15,833
0.0446%
$4.82$76,301-22.1%
2021-11-26SaleViracta Therapeutics, Inc.
VIRX
CEO & President
11,914
0.0316%
$4.80$57,194-26.03%
2021-11-15PurchaseViracta Therapeutics, Inc.
VIRX
CEO & President
8,000
0.0213%
$5.56$44,480-34.11%
2016-03-08PurchaseSyndax Pharmaceuticals, Inc.
SNDX
director
150,000
2.925%
$12.00$1.8M-8.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.